On 2 April 2025, Myeloma Patients Europe (MPE) hosted a webinar titled “How do different countries make decisions on reimbursing new medicines?”. The session provided valuable insights into how European health systems approach reimbursement processes, cost-effectiveness, and patient access to new treatments.
Speaker
Tom Belleman, PhD candidate at the Erasmus School of Health Policy and Management (ESHPM), Erasmus University Rotterdam, delivered a 45-minute presentation followed by a 30-minute Q&A session.
Now Available Online
If you missed the live session, the full recording is available to watch here:
Watch the webinar on YouTube
About the Speaker
Tom Belleman’s research focuses on cost-effectiveness and market access for innovative health technologies, particularly in oncology. He holds degrees in Biomedical Sciences and Health Economics, Policy & Law.
The webinar was organised by Myeloma Patients Europe (MPE).
